HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Ricardo Zwirtes Selected Research
Ricardo Zwirtes Research Topics
Disease
3
Neoplasms (Cancer)
01/2020 - 01/2018
2
Glioblastoma (Glioblastoma Multiforme)
01/2020 - 01/2018
2
Chronic Hepatitis C
11/2016 - 11/2016
1
Disease Progression
01/2020
1
Vulvar Neoplasms (Vulvar Cancer)
11/2019
1
Carcinoma (Carcinomatosis)
11/2019
1
Hyperbilirubinemia
11/2016
1
Infections
11/2016
1
Myocardial Infarction
11/2013
1
Myocardial Ischemia (Ischemic Heart Diseases)
11/2013
1
Cardiovascular Diseases (Cardiovascular Disease)
11/2013
1
Dyslipidemias (Dyslipidemia)
11/2013
Drug/Important Bio-Agent (IBA)
3
Nivolumab
IBA
01/2020 - 01/2018
2
Ribavirin (Virazole)
FDA Link
Generic
11/2016 - 11/2016
1
Immune Checkpoint Inhibitors
IBA
01/2020
1
Bevacizumab (Avastin)
FDA Link
01/2020
1
Temozolomide (Temodar)
FDA Link
Generic
01/2020
1
Ipilimumab
IBA
01/2018
1
peginterferon lambda-1a
IBA
11/2016
1
peginterferon alfa-2a (Pegasys)
FDA Link
11/2016
1
telaprevir
IBA
11/2016
1
daclatasvir
IBA
11/2016
1
Transaminases (Aminotransferases)
IBA
11/2016
1
Bilirubin
IBA
11/2016
1
Protease Inhibitors (Protease Inhibitor)
IBA
11/2013
1
Triglycerides (Triacylglycerol)
IBA
11/2013
1
LDL Lipoproteins (beta Lipoproteins)
IBA
11/2013
1
Cholesterol
IBA
11/2013
Therapy/Procedure
2
Therapeutics
01/2020 - 11/2016
1
Immunotherapy
01/2018
1
Highly Active Antiretroviral Therapy (HAART)
11/2013